CClinicalTrials.gg
CompletedNCT07667920NST-AFFIRMATIOUpdated Jun 25, 2026

The Effect of Affirmation During Non-Stress Test on Pain, Anxiety, Fear, and Stress

An interventional study of Affirmation Practice During Non-Stress Test in Pregnancy, Pain and Anxiety, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2025, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

This study will examine whether positive affirmations used during the Non-Stress Test (NST) can help reduce pain, anxiety, fear, and stress in pregnant women. The NST is a routine test used during pregnancy to assess fetal well-being. In this randomized controlled study, 90 pregnant women will participate. Some participants will repeat affirmation statements during the NST, while others will receive standard care. Pain, anxiety, fear, and stress levels will be measured before and after the NST. The goal of the study is to understand whether affirmations can make the NST experience more comfortable for pregnant women.

02

Conditions studied

  • Pregnancy
  • Pain
  • Anxiety
  • Fear
  • Stress

Keywords

  • Non-Stress Test
  • Pregnancy
  • Pain
  • Fear
  • Randomized Controlled Trial
03

In context

Pain

2,219 studies on the registry are indexed under Pain; 917 are open to participants now.

This study's enrollment of 90 is above the median of 70 across 1,904 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Saglik Bilimleri Universitesi is the lead sponsor of 430 studies on the registry; 137 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Pregnant women admitted to the clinic for the Non-Stress Test
  • Pregnant women between 32 and 41 weeks of gestation
  • Turkish citizens
  • Women aged 20 to 35 years
  • Women who voluntarily agree to participate in the study and provide informed consent
  • Women who have emptied their bladder immediately before the NST
  • Women who have eaten at least two hours before the NST

Exclusion criteria

Exclusion Criteria:

  • High-risk pregnancy, such as preeclampsia or multiple pregnancy
  • Inability to read and write Turkish
  • Any health problem in the mother or fetus
  • Known psychiatric disorder
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Affirmation Group 1

    Pregnant women with a normal pregnancy process will receive affirmation practice during the Non-Stress Test. During the NST procedure, participants will repeat positive affirmation statements to support relaxation and reduce pain, anxiety, fear, and stress.

    Behavioral: Affirmation Practice During Non-Stress Test

  • Experimental
    Affirmation Group 2

    Pregnant women who require a repeated Non-Stress Test due to decreased fetal movements or pain will receive affirmation practice during the Non-Stress Test. During the NST procedure, participants will repeat positive affirmation statements to support relaxation and reduce pain, anxiety, fear, and stress.

    Behavioral: Affirmation Practice During Non-Stress Test

  • No intervention
    Control Group

    Participants in this arm did not receive the affirmation intervention during NST.

Interventions

  • BehavioralAffirmation Practice During Non-Stress Test

    Pregnant women in the affirmation groups will repeat positive affirmation statements during the Non-Stress Test. The affirmation practice will be applied during the NST procedure to support relaxation and reduce pain, anxiety, fear, and stress.

06

What researchers measure

Primary outcomes

  1. Anxiety Level

    Anxiety level will be assessed using the State Anxiety Inventory before and after the Non-Stress Test. Higher scores indicate higher anxiety levels.

    Time frame: Before and immediately after the Non-Stress Test

07

Study locations

1 site
  • Esenler Maternity and Child Diseases Hospital
    Istanbul, 34668, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study includes sensitive health-related data from pregnant women. Participant confidentiality and privacy will be protected, and the data will be used only for the purposes of this study and related scientific reporting.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07667920
Lead sponsor
Saglik Bilimleri Universitesi
Responsible party
Enzel Köksaldı (PhD Student, Saglik Bilimleri Universitesi) — Principal investigator
First posted
Jun 25, 2026
Start date
Nov 10, 2025
Primary completion
May 5, 2026
Completion
May 5, 2026
Last update
Jun 25, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion